Keith Aqua, MD
Obstetrics & Gynecology · Wellington, FLNPI 1336105600
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (46.5%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 35 manufacturers reported payments, led by Acessa Health Inc. at 47.2% of the total. Reporting peaked in 2023 at $169,035 and has fallen 90.1% since, to $16,750 in 2025. Among obstetrics & gynecology clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 734 payments — averaging $644.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Acessa Health Inc.$223K
- AbbVie$123K
- Myovant Sciences Inc.$33K
- Lupin Inc.$32K
- Hologic Sales And Service, LLC$19K
- Sumitomo Pharma America, Inc.$15K
- plus $28K from 29 others
Across 59 payments — averaging $4319.33 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$255K
What the payments were for
- Consulting fees$220,17347%
- Speaking & faculty fees$194,31441%
- Travel & lodging$44,3099%
- Food & beverage$14,4193%
- Education$1830%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Acessa Health Inc. | 128 | $223,351 |
| AbbVie(2 entities) | 208 | $122,843 |
| Myovant Sciences Inc. | 58 | $32,891 |
| Lupin Inc. | 37 | $31,852 |
| Hologic Sales And Service, LLC | 118 | $19,272 |
| Sumitomo Pharma America, Inc. | 36 | $14,689 |
| Therapeuticsmd, Inc. | 24 | $11,438 |
| Bolder Surgical, LLC | 1 | $8,366 |
| Intra-sana Laboratories | 18 | $3,453 |
| Bayer | 4 | $1,436 |
| Royal Biologics, Inc. | 2 | $1,100 |
| Channel Medsystems, Inc. | 2 | $441 |
| Astellas Pharma US Inc | 16 | $432 |
| Acelrx Pharmaceuticals, Inc. | 1 | $400 |
| Mayne Pharma Commercial LLC | 11 | $294 |
| Kvk-tech, Inc. | 27 | $250 |
| Gynesonics, Inc. | 3 | $151 |
| Millicent US Inc | 4 | $105 |
| Exeltis, USA Inc. | 5 | $97 |
| Pfizer | 6 | $87 |
| Agile Therapeutics, Inc. | 4 | $58 |
| Novo Nordisk | 4 | $55 |
| Momentis Surgical Inc. | 1 | $44 |
| Avion Pharmaceuticals | 3 | $41 |
| BD | 1 | $38 |
| Biogen | 2 | $36 |
| Covidien LP | 2 | $33 |
| Lilly USA, LLC | 1 | $22 |
| Daiichi Sankyo Inc. | 1 | $22 |
| Organon | 1 | $22 |
| Amgen | 1 | $17 |
| Boston Scientific | 1 | $17 |
| Baxter Healthcare | 1 | $16 |
| Mycovia Pharmaceuticals, Inc. | 1 | $15 |
| AMAG Pharmaceuticals, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ACESSA PROVU SYSTEM$233,673
- Orilissa$79,120
- MYFEMBREE$46,591
- ORIAHNN$45,251
- SOLOSEC$31,477
- NovaSure$9,043
- BIJUVA$7,093
- Reltone 200 Mg$3,122
- GLYCATE$3,122
- Reltone 400 Mg$3,122
- IMVEXXY$2,004
- ANNOVERA$2,004
- Kyleena$1,385
- Mirena$1,385
- AmnioMaxx$1,100
- MYOSURE TISSUE REMOVAL DEVICE$1,072
- NONE$543
- CERENE CRYOTHERAPY DEVICE$420
- DSUVIA$400
- FLUENT FLUID MANAGEMENT SYSTEM$160
How this compares
$473,397 in reported general payments places this provider in the 95th percentile of 2,438 obstetrics & gynecology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 21 | $1,899 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Wellington
- Steven McCarusCelebration$2.3M
- Elliot CazesTampa$725K
- Charles BloomWinter Park$652K
- Jay CohenPlantation$556K
- Omar ZwainWinter Park$531K
- Jeffrey KotzenPalm Beach Gardens$413K
- Glenn BankertCrestview$388K
- Erica StockwellCelebration$321K
- Scott JordanFort Lauderdale$316K
- Daniel GomezTampa$311K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.